You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 290 No. 22, December 10, 2003 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (34)
 •Contact me when this article is cited
 Related Content
 •Related letters
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •Obesity
 •Hypertension
 •Women's Health, Other
 •Alert me on articles by topic

Inflammation, Hypertension, and the Metabolic Syndrome

Scott M. Grundy, MD, PhD

JAMA. 2003;290:3000-3002.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In this issue of THE JOURNAL, Sesso and colleagues1 report a positive relationship between increased serum levels of C-reactive protein and the risk for development of incident hypertension in participants of the Women's Health Study. A total of 20 525 women were followed up prospectively for a median of 7.8 years, during which time approximately one fourth of the women acquired elevated blood pressure; those with higher levels of C-reactive protein were more likely to develop hypertension. C-reactive protein levels in the upper ranges of the normal distribution (high-normal levels of C-reactive protein) are widely believed to reflect a state of low-grade chronic inflammation; therefore, the association between higher C-reactive protein levels and new-onset hypertension led Sesso et al1 to suggest that hypertension may be an inflammatory disease.

The term inflammation is applied by Sesso et al1 because higher levels of C-reactive protein are thought to . . . [Full Text of this Article]

Author Affiliations: Departments of Clinical Nutrition, Internal Medicine, and the Center for Human Nutrition, University of Texas Southwestern Medical Center, Dallas.


RELATED LETTERS

Etiology of the Metabolic Syndrome
Albert J. Miller
JAMA. 2004;291(12):1443.
EXTRACT | FULL TEXT  

Etiology of the Metabolic Syndrome
Akira Taguchi
JAMA. 2004;291(12):1443-1444.
EXTRACT | FULL TEXT  

Etiology of the Metabolic Syndrome—Reply
Scott M. Grundy
JAMA. 2004;291(12):1444.
EXTRACT | FULL TEXT  

RELATED ARTICLE

C-Reactive Protein and the Risk of Developing Hypertension
Howard D. Sesso, Julie E. Buring, Nader Rifai, Gavin J. Blake, J. Michael Gaziano, and Paul M. Ridker
JAMA. 2003;290(22):2945-2951.
ABSTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Salivary Lysozyme and Prevalent Hypertension
Qvarnstrom et al.
J. Dent. Res. 2008;87:480-484.
ABSTRACT | FULL TEXT  

T-cells in angiotensin-II-induced vascular damage
Helmut
Nephrol Dial Transplant 2008;23:1107-1108.
FULL TEXT  

Diet, Exercise, and C-Reactive Protein Levels in People With Abdominal Obesity: The ATTICA Epidemiological Study
Pitsavos et al.
ANGIOLOGY 2007;58:225-233.
ABSTRACT  

Multiple Biomarkers and the Risk of Incident Hypertension
Wang et al.
Hypertension 2007;49:432-438.
ABSTRACT | FULL TEXT  

Comparison of Interleukin-6 and C-Reactive Protein for the Risk of Developing Hypertension in Women
Sesso et al.
Hypertension 2007;49:304-310.
ABSTRACT | FULL TEXT  

Inflammation and hypertension: the search for a link
Pauletto and Rattazzi
Nephrol Dial Transplant 2006;21:850-853.
FULL TEXT  

Longitudinal study of soy food intake and blood pressure among middle-aged and elderly Chinese women
Yang et al.
Am. J. Clin. Nutr. 2005;81:1012-1017.
ABSTRACT | FULL TEXT  

C-reactive protein does not relax vascular smooth muscle: effects mediated by sodium azide in commercially available preparations
Swafford et al.
Am. J. Physiol. Heart Circ. Physiol. 2005;288:H1786-H1795.
ABSTRACT | FULL TEXT  

Association Between Elevated Liver Enzymes and C-Reactive Protein: Possible Hepatic Contribution to Systemic Inflammation in the Metabolic Syndrome
Kerner et al.
Arterioscler. Thromb. Vasc. Bio. 2005;25:193-197.
ABSTRACT | FULL TEXT  

Inflammation, Abdominal Obesity, and Smoking as Predictors of Hypertension
Niskanen et al.
Hypertension 2004;44:859-865.
ABSTRACT | FULL TEXT  

The Metabolic Syndrome, Inflammation, and Risk of Cognitive Decline
Yaffe et al.
JAMA 2004;292:2237-2242.
ABSTRACT | FULL TEXT  

Should C-Reactive Protein Be Added to Metabolic Syndrome and to Assessment of Global Cardiovascular Risk?
Ridker et al.
Circulation 2004;109:2818-2825.
ABSTRACT | FULL TEXT  

Etiology of the Metabolic Syndrome
Miller
JAMA 2004;291:1443-1443.
FULL TEXT  

Etiology of the Metabolic Syndrome
Taguchi
JAMA 2004;291:1443-1444.
FULL TEXT  

Link Between Elevated CRP and Incident Hypertension
Journal Watch Cardiology 2004;2004:3-3.
FULL TEXT  

Is Hypertension an Inflammatory Condition?
JWatch General 2004;2004:3-3.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.